A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.
第一作者:
Byron L,Cryer
第一单位:
University of Texas Southwestern Medical Center, Dallas, USA. Byron.Cryer@UTSouthwestern.edu
作者:
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);消炎药, 非甾类(Anti-Inflammatory Agents, Non-Steroidal);抗溃疡病药(Anti-Ulcer Agents);环氧化酶2抑制剂(Cyclooxygenase 2 Inhibitors);双盲法(Double-Blind Method);复方合剂(Drug Combinations);消化不良(Dyspepsia);女(雌)性(Female);胃肠道(Gastrointestinal Tract);胃灼热(Heartburn);人类(Humans);男(雄)性(Male);中年人(Middle Aged);萘普生(Naproxen);骨关节炎, 膝(Osteoarthritis, Knee);吡唑类(Pyrazoles);磺胺类(Sulfonamides);片剂, 肠衣(Tablets, Enteric-Coated);治疗结果(Treatment Outcome)
DOI
10.3109/07853890.2011.625971
PMID
22017620
发布时间
2015-11-19
- 浏览24

Annals of medicine
594-605页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文